Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and 50 in Subjects With Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01620424
Recruitment Status : Completed
First Posted : June 15, 2012
Last Update Posted : January 5, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S